Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $209,657,140 | $198,148,562 | $225,843,520 | $252,778,680 |
| - Cash | $18,169,000 | $8,007,000 | $8,629,000 | $13,242,000 |
| + Debt | $41,374,000 | $35,402,000 | $34,844,000 | $38,270,000 |
| Enterprise Value | $232,862,140 | $225,543,562 | $252,058,520 | $277,806,680 |
| Revenue | $17,276,000 | $15,806,000 | $15,529,000 | $15,624,000 |
| % Growth | 9.3% | 1.8% | -0.6% | – |
| Gross Profit | $14,152,000 | $12,249,000 | $12,110,000 | $11,796,000 |
| % Margin | 81.9% | 77.5% | 78% | 75.5% |
| EBITDA | $8,137,000 | $6,423,000 | $7,315,000 | $5,695,000 |
| % Margin | 47.1% | 40.6% | 47.1% | 36.5% |
| Net Income | $5,785,000 | $4,427,000 | $5,079,000 | $3,743,000 |
| % Margin | 33.5% | 28% | 32.7% | 24% |
| EPS Diluted | 2.32 | 1.76 | 2.01 | 1.48 |
| % Growth | 31.8% | -12.4% | 35.8% | – |
| Operating Cash Flow | $7,822,000 | $3,293,000 | $2,500,000 | $3,450,000 |
| Capital Expenditures | -$987,000 | -$764,000 | -$1,328,000 | -$937,000 |
| Free Cash Flow | $6,835,000 | $2,529,000 | $1,172,000 | $2,513,000 |